Epoetin beta

Epoetin beta
Clinical data
Pronunciation	/ɛˈpoʊ.ɪtɪn/
Trade names	Neorecormon, Betapoietin, others
AHFS/Drugs.com	International Drug Names
License data	EU EMA: by INN;
Pregnancy; category	AU: B3;
Routes of; administration	Intravenous, subcutaneous
ATC code	B03XA01 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); EU: Rx-only; In general: ℞ (Prescription only);
Identifiers
CAS Number	122312-54-3 ;
DrugBank	DB00016 ;
ChemSpider	none;
UNII	64FS3BFH5W;
KEGG	D03232 ;
	(what is this?) (verify)

Epoetin beta (INN), sold under the brand name Neorecormon among others, is a synthetic, recombinant form of erythropoietin, a protein that promotes the production of red blood cells. It is an erythropoiesis-stimulating agent (ESA) that is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy.

It is on the World Health Organization's List of Essential Medicines.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.